STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #481 by analyst upside · 2026-09-05
SLGL
Sol-Gel Technologies Ltd.
Healthcare · Market Cap $228M · P/E 0x
ANALYST PRICE TARGET
+182.9%
implied upside to consensus target
Current Price $69.52
Consensus Target $196.67
Bull Target $285.0
Bear Target $110.0
Analysts Covering 3
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
3
Hold
0
Sell
0
52-Week Low $23.13
52-Week High $97.97
YTD Return +64.9%
FUNDAMENTALS
Market Cap $228M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-5.61
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $2M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $23.13
52-Week High $97.97
Current Price $69.52
Bear Target $110.0
Bull Target $285.0
● Now $69.52 ● Target $196.67
TRADING DATA
Avg Volume 51K
YTD Return +64.9%
Analyst Count 3
Consensus Buy
Upside to Target +182.9%
Last Updated 2026-09-05

ANALYST SUMMARY

Sol-Gel Technologies Ltd. (SLGL) is currently trading at $69.52 with a Wall Street consensus price target of $196.67, implying potential upside of 182.9% over the next 12 months. 3 analysts currently cover SLGL, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $285.0, while the most cautious has a target of $110.0.

SLGL operates in the Healthcare sector with a market capitalisation of $228M. The stock is up 64.9% year-to-date and is currently trading near the upper end of its 52-week range of $23.13 – $97.97.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SLGL, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. reit
Buy → Buy 2026-07-20 31% win rate (48 calls)
Mizuho ● Initiated
Outperform 2026-06-24 Building track record
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-01-20 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-12-22 31% win rate (48 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2025-10-27 31% win rate (48 calls)
Raymond James ↓ Downgrade
Strong Buy → Outperform 2024-08-19 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
38
out of 100
Coverage depth
11/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →